4//SEC Filing
GARRETT J STEVEN 4
Accession 0001260651-04-000005
CIK 0000809875other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 3:16 PM ET
Size
8.8 KB
Accession
0001260651-04-000005
Insider Transaction Report
Form 4
GARRETT J STEVEN
Senior VP Clinical Research
Transactions
- Sale
Common Stock, $.001 Par Value
2004-04-16$29.26/sh−2,000$58,520→ 12,900 total - Exercise/Conversion
Non-Qualified Stock Option (Right-To-Buy)
2004-04-16$15.56/sh−2,000$31,126→ 8,000 totalExercise: $15.56From: 2001-08-30Exp: 2010-08-30→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock, $.001 Par Value
2004-04-16$15.56/sh+2,000$31,126→ 14,900 total
Footnotes (1)
- [F1]The non-qualified option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the beneficial owner.
Documents
Issuer
ATRIX LABORATORIES INC
CIK 0000809875
Entity typeother
Related Parties
1- filerCIK 0001260651
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 3:16 PM ET
- Size
- 8.8 KB